Rabbi Shmulevitz was diagnosed with ALS four months ago and given two to four years to live. Now, able to walk and talk again after treatment.
In January we reported on an Israeli biotechnology company, BrainStorm, which announced successful results in its clinical trial for a treatment against ALS (Amyotrophic Lateral Sclerosis) – a fatal neurodegenerative disease also known as Lou Gehrig’s disease.

Rabbi Refael Shmulevitz (Right) – Image courtesy of Israel’s Channel Two
Less than six months later, Israeli Channel Two audiences last night were moved to see an ailing rabbi, who had been diagnosed with ALS, able to walk and talk again after being treated with Brainstorm‘s ‘NurOwn.’ Continue Reading »